Description:

CALGB Randomization (CALGB 49903) NCT00053339 Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A73D2B92-2BAF-4794-E034-0003BA0B1A09

Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A73D2B92-2BAF-4794-E034-0003BA0B1A09
Keywords:
  1. 12/18/14 12/18/14 - Martin Dugas
  2. 1/9/15 1/9/15 - Martin Dugas
  3. 7/5/15 7/5/15 -
  4. 9/20/21 9/20/21 -
Uploaded on:

September 20, 2021

DOI:
To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

CALGB Randomization (CALGB 49903) NCT00053339

No Instruction available.

  1. StudyEvent: CALGB Randomization (CALGB 49903)
    1. No Instruction available.
Header
Protocol Administration
Patient Demographics / Pre-treatment Characteristics
Patient Race/Ethnicity
Sex
Method of Payment
Performance Status
Certification Of Eligibility
Patient eligible? (STRATIFICATION FACTORS)
Registration data
ASSIGNED TREATMENT ARM
Ccrr Module For Calgb Randomization (calgb 49903)

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial